TL;DR
Get comfort and care essentials delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
An October 4 MedPage Today opinion article argues that routine antibiotic use in food animals is an upstream contributor to drug resistance encountered in clinics. It points to China’s restriction on colistin use in animal feed and subsequent declines in resistance as evidence that policy can affect resistance, while noting that the scale of the contribution to U.S. infections remains difficult to pin down.
A physician’s commentary published by MedPage Today on October 4 argues that routine antibiotic use in food animals contributes to drug resistance seen in human infections, and that stewardship focused only on prescriptions in clinics and hospitals misses part of the problem. Hana Kahleova, MD, PhD, points to China’s 2017 ban on colistin as an animal-feed additive and subsequent declines in resistance as evidence that changes in agricultural policy can affect resistance beyond farms.
Kahleova writes that about 70% of antibiotics considered important to human medicine in the United States are sold for use in food animals. She says much of that use is not to treat sick livestock, but to prevent illness among healthy animals raised in crowded conditions. The figure and its characterization are presented in the commentary; the article does not provide a separate analysis of the underlying sales data.
The commentary describes several routes by which resistant organisms or genes may move beyond farms, including meat, water, dust, workers and manure. It argues that these pathways can eventually affect human infections, while emphasizing that clinicians often encounter resistant organisms without tracing their origin. The article does not quantify how many U.S. infections are attributable to animal antibiotic use.
As a policy example, Kahleova cites mcr-1, a transferable gene associated with resistance to colistin, a drug reserved for some difficult-to-treat infections. The gene emerged during colistin use as a growth promoter on Chinese pig farms and was later detected in patient isolates in multiple countries, according to the commentary. After China banned colistin as a feed additive in 2017, resistance declined in animals and people, Kahleova writes. The article presents that sequence as evidence policy can help, not as proof that agricultural use explains every resistant infection.
Resistance Beyond the Hospital
The argument matters to patients and clinicians because resistant infections can leave fewer effective treatment options, while many interventions in health care focus on how antibiotics are prescribed to people. If some resistance is driven by use elsewhere in the food system, clinic-based stewardship alone cannot address every source of selection pressure.
Kahleova cites estimates that drug-resistant infections kill about 35,000 people in the United States each year and refers to a Lancet forecast of roughly 39 million deaths globally from resistant infections between now and 2050. These are estimates and projections, not counts tied specifically to food-animal use. The commentary’s practical point is that the potential scale of resistance makes it relevant to examine upstream practices as well as bedside decisions.
The proposed actions span different levels: the World Health Organization has urged ending routine preventive antibiotic use in animals that are not sick; clinicians can discuss food choices with patients; and hospitals can review food-service purchasing. Kahleova says these steps would complement, rather than replace, farm-level regulation and treatment of genuinely sick animals.
As an affiliate, we earn on qualifying purchases.
The Colistin Policy Example
Colistin is used in human medicine as a reserve option for some infections resistant to other drugs. Kahleova’s commentary says its use as a low-cost growth promoter on Chinese pig farms was associated with the emergence and spread of the transferable mcr-1 resistance gene. Finding the gene in patient isolates across multiple continents illustrated how resistance can move beyond the setting where antibiotic use began.
China prohibited colistin as a feed additive in 2017. The commentary says resistance subsequently fell in both animals and people, describing the policy change as a real-world example of targeted restrictions having measurable effects. This case supports the possibility that reducing a particular use can reduce associated resistance; it does not establish the size of the contribution from livestock to all human resistance, or show that every antibiotic restriction will have the same result.
The World Health Organization’s recommendation, as described by Kahleova, targets routine preventive antibiotic use in healthy animals. It is not a call to stop veterinary care: animals that are ill may still need antibiotics. The distinction is between treatment and regular use to prevent illness or support production in healthy animals.
How Much Comes From Farms
The commentary does not estimate what proportion of resistant infections in the United States can be directly traced to antibiotic use in food animals. Nor does it provide a detailed account of the studies behind the 70% sales figure, the annual U.S. death estimate or the global forecast. Those figures should not be read as showing that all the cited deaths stem from agricultural use.
The China example describes a decline in resistance after a policy change, but the commentary does not give the data, time period or size of that decline. The relative contribution of different routes—such as food, water, dust and contact with workers—also remains unquantified here. Further evidence is needed to distinguish the effect of farm use from other sources and to assess how well results from one country and drug apply elsewhere.
Policy and Purchasing Choices
Kahleova calls on clinicians to support restrictions on routine preventive antibiotic use in healthy animals through professional societies, while maintaining access to veterinary treatment for sick animals. The commentary does not announce a new regulation or a government action; it is an argument for broader stewardship, not a report of a policy already adopted.
She also proposes steps health professionals and institutions can take without waiting for new rules: discussing more plant-forward diets when appropriate, reducing demand for meat produced in systems reliant on routine antibiotic use, and reviewing hospital food-service contracts. The article does not present outcome data showing how much these measures would reduce resistance. The next test is whether health systems, professional groups and policymakers put these options alongside clinical prescribing practices—and whether subsequent monitoring can measure their effects.
Key Questions
What is the main claim of the commentary?
Hana Kahleova argues that routine antibiotic use in food animals is an upstream contributor to resistance seen in human medicine, so stewardship should include agricultural practices as well as prescribing in hospitals and clinics.
Does the article say antibiotics should never be used in livestock?
No. It distinguishes routine preventive use in healthy animals from treatment for illness and says genuinely sick animals still need veterinary care.
What happened with colistin in China?
The commentary says China banned colistin as a feed additive in 2017, after the drug’s use on pig farms had been associated with the spread of the transferable resistance gene mcr-1. Kahleova reports that resistance later declined in animals and people, but the article does not provide the size or timing of that decline.
How many resistant infections come from food-animal use?
The commentary does not give a figure for the share of human infections attributable to livestock antibiotic use. It describes possible routes of spread and a policy example, but the contribution to U.S. cases remains unquantified in the article.
What actions does Kahleova suggest?
She calls for support of targeted farm-level rules, and suggests clinicians discuss food choices and hospitals review food purchasing. She presents these as additional measures, not replacements for careful antibiotic prescribing or appropriate treatment of sick animals.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
